All enrolled individuals who received at the very least just one dose of zosuquidar or placebo for the duration of induction have been monitored for your occurrence of adverse gatherings (439 clients, 219 on zosuquidar and 210 on placebo). The most common adverse events were being relevant to the period https://juliaq888coy0.blogdun.com/profile